PE Tech Report


Like this article?

Sign up to our free newsletter

Inflexxion gets infusion of PE capital

Inflexxion, a developer of behavioural change programs that reduce health-related risks, has secured investments from Periscope Equity, Fidus Investment Corporation, and Akoya Capital Partners. 

Consilium Partners, a Boston-based investment bank, acted as the exclusive financial advisor to the Company in connection with the transaction. 

The financial investment validates Inflexxion's leadership position in the healthcare data analytics space, and positions the company for continued expansion.

"We are excited to work with our new investment partners," says Simon Budman, PhD, CEO and Founder of Inflexxion. "By leveraging the financial experience and access to capital of our investors, the Inflexxion Management Team will be able to take advantage of new opportunities in the market and aggressively grow the company."

Dr Budman will continue to stay actively involved with Inflexxion by remaining in his current role of CEO and will serve on the board of directors. The board will have several other non-executive directors led by John J Regazzi, Managing Director of Akoya Capital Partners and former CEO of Elsevier, Inc.

In addition to the investment, Thomas Hegelund joins Inflexxion as President. Previously, Hegelund was Senior Vice President and General Manager at Truven Health Analytics where he was responsible for the Clinical Solutions Division.

Like this article? Sign up to our free newsletter